Science ❯Medical Research ❯Vaccine Research
Malaria Vaccine Trials Experimental Vaccines Funding Sources mRNA Vaccine Trials mRNA Technology Safety Studies Next-Generation Vaccines
The move shrinks its staff to under 5,000 by year-end to cut $1.5 billion in annual expenses by 2027.